SCHEMBL3205815

SCHEMBL3205815

CCOc1cc(N(Cc2cncs2)c2ccc(C(=O)OC(C)(C)C)cc2)ccc1OC

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.38
MAPK1 P28482 2/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
TP53 P04637 1/20 0.36
TSHR P16473 2/20 0.35
HDAC6 Q9UBN7 1/20 0.35
PARP15 Q460N3 1/20 0.35
PARP10 Q53GL7 1/20 0.35
PDE4A P27815 5/20 0.35
PDE4B Q07343 5/20 0.35
PDE4C Q08493 5/20 0.35
PDE4D Q08499 5/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
SREBF1 P36956 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3204089 0.96 TSHR (0.40) HRH4MAPK1TRPM8TSHRHDAC6
SCHEMBL3201995 0.95 HRH4 (0.39) HRH4MAPK1TRPM8TSHRHDAC6
SCHEMBL3205143 0.93 ALDH1A1 (0.38) MAPK1TRPM8TSHRHDAC6PARP15
SCHEMBL3218540 0.90 RXRA (0.40) HRH4MAPK1TRPM8HDAC6PARP15
SCHEMBL3125802 0.90 RAB9A (0.39) HRH4MAPK1TRPM8HDAC6PDE4A
SCHEMBL3126048 0.89 SREBF1 (0.41) HRH4MAPK1TRPM8TSHRL3MBTL1
SCHEMBL3199311 0.88 RXRA (0.37) MAPK1TRPM8HDAC6PARP15PARP10
SCHEMBL3215147 0.88 TSHR (0.46) HRH4MAPK1TRPM8TP53TSHR
SCHEMBL3215114 0.88 HDAC6 (0.36) MAPK1TP53TSHRHDAC6PARP15
SCHEMBL3219592 0.87 NR1H2 (0.40) HRH4TRPM8KDM4EMAPTSREBF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B HRH4 442/4885MAPK1 1371/4885TRPM8 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.